Open AccessLeft Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study
Author(s) -
Tsao Connie W.,
Gona Philimon N.,
Salton Carol J.,
Chuang Michael L.,
Levy Daniel,
Manning Warren J.,
O'Donnell Christopher J.
Publication year - 2015
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.115.002188
Subject(s) - medicine , cardiology , framingham risk score , myocardial infarction , framingham heart study , ventricular remodeling , concentric hypertrophy , left ventricular hypertrophy , heart failure , disease , blood pressure
Background Elevated left ventricular mass index ( LVMI ) and concentric left ventricular ( LV ) remodeling are related to adverse cardiovascular disease ( CVD ) events. The predictive utility of LV concentric remodeling and LV mass in the prediction of CVD events is not well characterized. Methods and Results Framingham Heart Study Offspring Cohort members without prevalent CVD (n=1715, 50% men, aged 65±9 years) underwent cardiovascular magnetic resonance for LVMI and geometry (2002–2006) and were prospectively followed for incident CVD (myocardial infarction, coronary insufficiency, heart failure, stroke) or CVD death. Over 13 808 person‐years of follow‐up (median 8.4, range 0.0 to 10.5 years), 85 CVD events occurred. In multivariable‐adjusted proportional hazards regression models, each 10‐g/m 2 increment in LVMI and each 0.1 unit in relative wall thickness was associated with 33% and 59% increased risk for CVD , respectively ( P =0.004 and P =0.009, respectively). The association between LV mass/ LV end‐diastolic volume and incident CVD was borderline significant ( P =0.053). Multivariable‐adjusted risk reclassification models showed a modest improvement in CVD risk prediction with the incorporation of cardiovascular magnetic resonance LVMI and measures of LV concentricity (C‐statistic 0.71 [95% CI 0.65 to 0.78] for the model with traditional risk factors only, improved to 0.74 [95% CI 0.68 to 0.80] for the risk factor model additionally including LVMI and relative wall thickness). Conclusions Among adults free of prevalent CVD in the community, greater LVMI and LV concentric hypertrophy are associated with a marked increase in adverse incident CVD events. The potential benefit of aggressive primary prevention to modify LV mass and geometry in these adults requires further investigation.